However, the minor allele, apoE4, when expressed in humans, can impair neuronal development, as well as shorten human lifespan by about four years and increase the risk of heart disease and Alzheimer disease by several-fold. ApoE4 carriers have higher totals of blood cholesterol, more oxidized blood lipids and early onset of coronary heart disease and Alzheimer's disease.

"The chimpanzee apoE functions more like the "good" apoE3, which contributes to low levels of heart disease and Alzheimer's," Finch said. Correspondingly, chimpanzees in captivity have unusually low levels of heart disease and Alzheimer-like changes during aging.

Finch hypothesizes that the expression of ApoE4 could be the result of the antagonistic pleiotropy theory of aging, in which genes selected to fight diseases in early life have adverse affects in later life.

"ApoeE may be a prototype for other genes that enabled the huge changes in human lifespan, as well as brain size, despite our very unape-like meat-rich diets," Finch said. "Drugs being developed to alter activities of apoE4 may also enhance lifespan of apoE4 carriers."

Source: University of Southern California